Quantum Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,000
Closed -$223K 213
2021
Q4
$223K Buy
+2,000
New +$241K 0.08% 186

Other funds holding XBI

Quantum Private Wealth's XBI Position: Q1 2022 in Review

Quantum Private Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 2,000 shares — an estimated $223K sold.

Quantum Private Wealth first reported a position in XBI in Q4 2021 and held it in 1 quarter. The position peaked at $223K in Q4 2021. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

  • Quantum Private Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
  • Quantum Private Wealth sold 2,000 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $223K.
  • Quantum Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 1 quarter.
  • Quantum Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $223K in Q4 2021.
  • 703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Quantum Private Wealth's 13F filing for Q1 2022, filed 27 May 2022.